News & Media

Keep up to date with all of our latest news.

SparingVision Presents Additional Data on its Breakthrough Gene Therapy Approach SPVN06 at ASGCT 2022

SparingVision Presents Additional Data on its Breakthrough Gene Therapy Approach SPVN06 at ASGCT 2022 Data…

SparingVision Presents Additional Data on its Breakthrough Gene Therapy Approach SPVN06 at ASGCT 2022

SparingVision Presents Additional Data on its Breakthrough Gene Therapy Approach SPVN06 at ASGCT 2022 Data…

SparingVision Presents Progress of its Lead Gene Therapy Program, SPVN06, at ARVO 2022

SparingVision Presents Progress of its Lead Gene Therapy Program, SPVN06, at ARVO 2022 Paris, May…

SparingVision Announces Oral Presentation of SPVN06 Data at ASGCT 2022

SparingVision announces Oral Presentation of SPVN06 Data at ASGCT 2022 Paris, May 3, 2022 –…

SparingVision to Highlight Progress of its Lead Gene Therapy Program SPVN06 and Research on Retinitis Pigmentosa at ARVO 2022

SparingVision to Highlight Progress of its Lead Gene Therapy Program SPVN06 and Research on Retinitis…

SparingVision to Present at the 40th Annual J.P. Morgan Healthcare Conference

SparingVision to Present at the 40th Annual J.P. Morgan Healthcare Conference Paris, January 6…

SparingVision Strengthens Leadership Team with the Appointment of Dr Mehdi Gasmi as Chief Operating Officer

SparingVision Strengthens Leadership Team with the Appointment of Dr Mehdi Gasmi as Chief Operating Officer…

SparingVision to Present at Upcoming Investor Conferences

SparingVision to Present at Upcoming Investor Conferences Paris, December 3, 2021 – SparingVision (or the…

Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology

Cambridge, MA, and Paris, France– October 13, 2021 Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading…

SparingVision Conference Participation in H2 2021

SparingVision announces the scientific and investor conferences that its management team will be participating in…

SparingVision to Present at the American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting

SparingVision is pleased to announce that it will present a poster highlighting the Company’s recent…

News & Media Menu

LATEST TWEETS

SparingVision Follow

Genomic medicine company developing vision-saving treatments for ocular diseases #vision #blindness #genetherapy #biotech #healthtech

SparingVision @sparingvision ·

11 Aug

At SparingVision, we are building a portfolio of synergistic cutting-edge #genomicmedicines for inherited #retinaldiseases (IRDs) spanning 3 core pillars. Watch below as our CSO Deniz Dalkara discusses our 1st pillar: mutation-agnostic gene therapies. #Ophthalmology #GeneTherapy

Reply on Twitter 1557644846151700481 Retweet on Twitter 1557644846151700481 1 Like on Twitter 1557644846151700481 5 Twitter 1557644846151700481

SparingVision @sparingvision ·

9 Aug

Watch the first in a new video series below as our CEO, @BoisselStephane, outlines our 3-pillar strategy within the #genomicmedicines space which encompasses: mutation-agnostic #genetherapy, #genomeediting & in vivo reprogramming. For more: https://sparingvision.com/ #Ophthalmology

Reply on Twitter 1556935865800204291 Retweet on Twitter 1556935865800204291 2 Like on Twitter 1556935865800204291 4 Twitter 1556935865800204291

PARTNERS

01

Home

03

Patients

02

Technologies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	6 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	6 months	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_209804575_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
vuid	6 months	Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.

Others